Marie M Deschamps1, Barbara Metch, Cecilia A Morgan, Carmen D Zorilla, Yeycy Donastorg, Edith Swann, Dadaille Taina, Joseph Patrice, William J Pape. 1. *Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), Port-au-Prince, Haiti;†Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;‡Maternal and Infant Studies Center (CEMI), University of Puerto Rico School of Medicine, San Juan, PR;§Unidad de Vacunas IDCP-COIN-DIGECITSS, Santo Domingo, Dominican Republic; and‖Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.
Abstract
BACKGROUND: Identifying cohorts of Caribbean women with HIV infection rates sufficient for inclusion in HIV vaccine efficacy trials has been challenging. HVTN 907 determined the feasibility of identifying and retaining a cohort of women at high risk for HIV acquisition by focusing recruitment on female sex workers (FSWs). METHODS: HIV uninfected FSWs, residing in Haiti, Dominican Republic, and Puerto Rico, who reported unprotected sex and met previously described more stringent site-specific eligibility criteria, were eligible. Behavioral risk assessment, HIV counseling and testing, and pregnancy testing were performed at baseline, 6, 12, and 18 months. RESULTS: Among 799 FSWs (264 from Dominican Republic, 334 from Haiti, and 201 from Puerto Rico), the median age was 26 years, with 54% having less than a high school education and 45% having a monthly household income of less than $US 100. Median number of male partners 6 months before screening was 200. Retention at 18 months was 93%. Twelve women became HIV infected, 9 from Haiti. The annualized HIV incidence was 1.07% (95% confidence interval: 0.55% to 1.87%). Pregnancy incidence was 22.5% (95% confidence interval: 21.9% to 29.5%). Statistically significant declines in risk behaviors occurred between screening and the 18-month visit assessment. DISCUSSION: The HVTN 907 study identified a high-risk cohort of women with excellent retention for all 3 sites, despite major challenges especially in Haiti. These results show that a bridging study of a vaccine shown to be efficacious in other clade settings would be possible among FSWs in the region, particularly in Haiti.
BACKGROUND: Identifying cohorts of Caribbean women with HIV infection rates sufficient for inclusion in HIV vaccine efficacy trials has been challenging. HVTN 907 determined the feasibility of identifying and retaining a cohort of women at high risk for HIV acquisition by focusing recruitment on female sex workers (FSWs). METHODS:HIV uninfected FSWs, residing in Haiti, Dominican Republic, and Puerto Rico, who reported unprotected sex and met previously described more stringent site-specific eligibility criteria, were eligible. Behavioral risk assessment, HIV counseling and testing, and pregnancy testing were performed at baseline, 6, 12, and 18 months. RESULTS: Among 799 FSWs (264 from Dominican Republic, 334 from Haiti, and 201 from Puerto Rico), the median age was 26 years, with 54% having less than a high school education and 45% having a monthly household income of less than $US 100. Median number of male partners 6 months before screening was 200. Retention at 18 months was 93%. Twelve women became HIV infected, 9 from Haiti. The annualized HIV incidence was 1.07% (95% confidence interval: 0.55% to 1.87%). Pregnancy incidence was 22.5% (95% confidence interval: 21.9% to 29.5%). Statistically significant declines in risk behaviors occurred between screening and the 18-month visit assessment. DISCUSSION: The HVTN 907 study identified a high-risk cohort of women with excellent retention for all 3 sites, despite major challenges especially in Haiti. These results show that a bridging study of a vaccine shown to be efficacious in other clade settings would be possible among FSWs in the region, particularly in Haiti.
Authors: Deanna Kerrigan; Luis Moreno; Santo Rosario; Bayardo Gomez; Hector Jerez; Clare Barrington; Ellen Weiss; Michael Sweat Journal: Am J Public Health Date: 2005-11-29 Impact factor: 9.308
Authors: Marie Marcelle Deschamps; Carmen D Zorrilla; Cecilia A Morgan; Yeycy Donastorg; Barbara Metch; Tamra Madenwald; Patrice Joseph; Karine Severe; Sheyla Garced; Marta Perez; Gina Escamilia; Edith Swann; Jean William Pape Journal: Rev Panam Salud Publica Date: 2013-08
Authors: H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen Journal: JAMA Date: 2008-08-06 Impact factor: 56.272
Authors: Daniel T Halperin; E Antonio de Moya; Eddy Pérez-Then; Gregory Pappas; Jesus M Garcia Calleja Journal: J Acquir Immune Defic Syndr Date: 2009-05-01 Impact factor: 3.731
Authors: Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson Journal: Lancet Date: 2008-11-13 Impact factor: 79.321
Authors: Gaston Djomand; Barbara Metch; Carmen D Zorrilla; Yeycy Donastorg; Martin Casapia; Tonya Villafana; Jean Pape; Peter Figueroa; Marianne Hansen; Susan Buchbinder; Chris Beyrer Journal: J Acquir Immune Defic Syndr Date: 2008-05-01 Impact factor: 3.731
Authors: Jocelyn Elmes; Romain Silhol; Kristen L Hess; Lukyn M Gedge; Ashley Nordsletten; Roisin Staunton; Peter Anton; Barbara Shacklett; Ian McGowan; Que Dang; Adaora A Adimora; Dobromir T Dimitrov; Sevgi Aral; Senad Handanagic; Gabriela Paz-Bailey; Marie-Claude Boily Journal: Am J Reprod Immunol Date: 2020-06-09 Impact factor: 3.886
Authors: Frances H Ampt; Collins Mudogo; Peter Gichangi; Megan S C Lim; Griffins Manguro; Matthew Chersich; Walter Jaoko; Marleen Temmerman; Marilyn Laini; Liz Comrie-Thomson; Mark Stoové; Paul A Agius; Margaret Hellard; Kelly L'Engle; Stanley Luchters Journal: BMJ Open Date: 2017-08-18 Impact factor: 2.692
Authors: Hamid Sharifi; Ali Mirzazadeh; Mostafa Shokoohi; Mohammad Karamouzian; Razieh Khajehkazemi; Soodabeh Navadeh; Noushin Fahimfar; Ahmad Danesh; Mehdi Osooli; Willi McFarland; Mohammad Mehdi Gouya; Ali Akbar Haghdoost Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240
Authors: Ruchi Tiwari; Jiayu Wang; Hannah Han; Ngozi Kalu; Lee B Sims; David A Katz; Barbara Burke; Adino T Tsegaye; Kayla A Carter; Sophie Freije; Boya Guo; Mohamed Albirair; Magdalena Barr-DiChiara; Rachel Baggaley; Muhammad S Jamil; Kafui Senya; Cheryl Johnson; Christine M Khosropour Journal: J Int AIDS Soc Date: 2020-11 Impact factor: 5.396
Authors: Frances H Ampt; Lisa Willenberg; Paul A Agius; Matthew Chersich; Stanley Luchters; Megan S C Lim Journal: BMJ Open Date: 2018-09-17 Impact factor: 2.692